["Route": "Routes Of Administration For Opioid Antagonists"]
Performance/Reporting Period
2025
Value Set Description from VSAC
Clinical Focus: The purpose of this value set is to represent concepts for routes of administration for opioid antagonist administration to reverse opioid overdose which includes intranasal spray, inhalation, intramuscular, subcutaneous, or intravenous injection
Data Element Scope: This value set may use a model element related to routes of medication administrations for opioid antagonists
Inclusion Criteria: Includes concepts that represent intranasal, intramuscular, intravenous, subcutaneous, inhalation routes of administration for opioid antagonist administration
Exclusion Criteria: Excludes enteral routes and other routes that are not intranasal, inhalation, intramuscular, intravenous or subcutaneous such as intradermal, intracoronary, intradiscal, intrapulmonary, etc.
Data Element Scope: This value set may use a model element related to routes of medication administrations for opioid antagonists
Inclusion Criteria: Includes concepts that represent intranasal, intramuscular, intravenous, subcutaneous, inhalation routes of administration for opioid antagonist administration
Exclusion Criteria: Excludes enteral routes and other routes that are not intranasal, inhalation, intramuscular, intravenous or subcutaneous such as intradermal, intracoronary, intradiscal, intrapulmonary, etc.
Constrained to codes in the Routes of Administration for Opioid Antagonists value set (2.16.840.1.113762.1.4.1248.187)
QDM Datatype and Definition
route
Refers to the path by which the medication or substance should be taken into the body system, such as intradermally, intrathecally, intramuscularly, intranasally, intravenously, orally, rectally, subcutaneously, sublingually, topically, or vaginally.
eCQMs using this data element:
Last Updated: Jun 26, 2024